Related Experiment Video
Updated: Apr 19, 2026

10:13
A Technical Guide for Performing Spectroscopic Measurements on Metal-Organic Frameworks
Published on: April 28, 2023
3.3K
Zinc-Porphyrin Terephthalate-Based Metal-Organic Framework: Structural Insights and Functional Antibacterial
Kumar Shivam1, Ritam Das1, Manas K Panda2
1Amity Institute of Click Chemistry Research and Studies, Amity University Uttar Pradesh, Noida, Uttar Pradesh, India.
Chembiochem : a European Journal of Chemical Biology
|April 17, 2026
Summary
A novel zinc-based metal-organic framework (compound 2) shows enhanced antibacterial photodynamic therapy. It effectively combats MRSA and E. coli by producing reactive oxygen species upon red light irradiation.
Area of Science:
- Materials Science
- Nanotechnology
- Photochemistry
Background:
- Antibiotic resistance necessitates novel therapeutic strategies.
- Metal-organic frameworks (MOFs) offer tunable properties for various applications.
- Porphyrin-based materials are investigated for photodynamic therapy.
Purpose of the Study:
- To synthesize and characterize a mixed-linker zinc-based MOF (compound 2) for antibacterial photodynamic therapy.
- To compare its efficacy against a known porphyrin (compound 1).
- To elucidate the structure-property relationships governing its antibacterial activity.
Main Methods:
- Synthesis and crystal structure analysis of protonated 5,10,15,20-tetrakis(4-pyridyl)porphyrin (compound 1) and zinc-based MOF (compound 2).
- Surface area measurement using N2 adsorption.
- Molecular orbital calculations.
- Antibacterial photodynamic therapy assays under red light irradiation.
Main Results:
- Compound 2 forms an interpenetrated 3D framework with a high theoretical surface area (2915 m² g⁻¹).
- Molecular orbital calculations indicate porphyrin core localization of frontier orbitals.
- Compound 2 demonstrated enhanced reactive oxygen species production and superior antibacterial activity against MRSA and E. coli compared to compound 1.
- Significant inhibition zones of 28±1 mm (MRSA) and 21±1 mm (E. coli) were observed for compound 2.
Conclusions:
- The synthesized zinc-based MOF (compound 2) is a promising light-activated antibacterial platform.
- Its enhanced performance is attributed to its structure and electronic properties.
- This study provides a rational design approach for next-generation antibacterial agents.

